My PCR
Create Account
Logo PCR

20 May 2025

Renal denervation

Advancing renal denervation in China: from guidelines to practice

Anchorperson: J. Wang
Discussants: Y. Peng, J. YU, C. Lu, G. Zhai, Y. Xue
SHOW MORE

Summary

Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain practical guidance on performing RDN procedures in China, including imaging techniques like CTA and angiography, and best practices to ensure safety and effectiveness.

Learning Objectives

  • To learn how renal denervation developed in China
  • To learn how to select right patient for renal denervation based on China practice
  • To learn how to successfully navigate your renal denervation procedure
Related Content
Share your work at PCR-CIT China Chengdu Valves 2025 GulfPCR-GIM 2025: Call for Submissions is open New frontier in renal denervation: data, devices and developments
Recommended for you
AICT-AsiaPCR: what's in store this year? AICT-AsiaPCR: Call for Submissions is now open A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension